{ }
Cencora has agreed to acquire Retina Consultants of America for approximately $4.6 billion in cash, aiming to enhance its relationships with community providers and advance retinal care. The deal will give Cencora about 85% ownership of RCA, with potential additional payments of up to $500 million based on performance. This acquisition is expected to strengthen Cencora's specialty capabilities and expand its management services organization business.
Cencora, Inc. specializes in the distribution of pharmaceutical products, supplying both generic and originator drugs, OTC healthcare products, and homecare equipment to healthcare providers across the U.S. and Canada. The company also offers various services, including reimbursement support, prescription management, and home injection services for physicians and patients.
Cencora, Inc. is a key player in the distribution of pharmaceutical products, serving healthcare providers across the United States and Canada. The company offers a range of services, including generic and branded pharmaceuticals, over-the-counter healthcare products, and home care devices, along with support for physicians and patients in areas like reimbursement and prescription management. UBS has maintained a Buy recommendation for the company, highlighting its strong market position.
Proposed Medicare payment cuts threaten physician practices, particularly small, physician-owned ones, as reimbursement rates fail to keep pace with inflation. The Centers for Medicare and Medicaid Services plans a 2.8% reduction in the conversion factor for 2025, impacting various specialties, including a 3.5% decrease for urologists. With nearly half of qualified adults relying solely on Medicare, the need for stable provider markets is critical for maintaining access to quality care.
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Waitlist

We’re granting exclusive early access to the first 500 users from december 20.

© 2024 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings

Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.